OKYO Pharma (OKYO) Shareholder's Equity (2021 - 2025)

OKYO Pharma (OKYO) Shareholder's Equity (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 7.14 Bn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 795.79 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 595,226.00
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 14.38 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 19.36 Bn
9 Abivax 94.26 Bn 94.26 Bn - 502.95 Mn
10 OKYO Pharma 244.98 Mn 240.76 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 -5.55 Mn
Sep 30, 2024 -145.20 Mn
Mar 31, 2024 -5.88 Mn
Sep 30, 2023 135.39 Mn
Mar 31, 2023 -2.05 Mn
Mar 31, 2022 2.95 Mn
Mar 31, 2021 5.32 Mn